Colorectal Cancer

The team identified specific proteins — fibronectin and smooth muscle actin — associated with resistance to immunotherapy treatment in colorectal cancer tissues.

Dr. Derek Ebner, a Mayo Clinic gastroenterologist, explains what colorectal cancer is, who is at risk, and when to get screened.

Dr. Derek Ebner shares what you need to know to prevent colorectal cancer or catch it early when it's most treatable.

Dr. Katherine Poruk discusses hepatic artery infusion pump chemotherapy, an option for some people with colorectal cancer that has spread to the liver.

Brian Principe was diagnosed with colon cancer that had spread to his liver. After liver-directed chemotherapy, his tumors have shrunk, and he is helping others prevent the disease.

An overview of the 10 most popular articles Mayo Clinic Comprehensive Cancer Center Blog published in 2024.

Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to reveal insights that improve patient care.

Cris Ross, chief information officer at Mayo Clinic, shares his experience of rehabilitation and healing after colorectal cancer treatment and recurrence.

Cris Ross, chief information officer at Mayo Clinic, shares his experience of completing colorectal cancer treatment, then learning that his cancer had returned.

Cris Ross, chief information officer at Mayo Clinic, shares his experience of becoming a colorectal cancer patient and coping with the side effects of chemotherapy, radiation and surgery.